Healionics Corp. Press Releases - EIN Presswire - Press Release Distribution Service

Published on November 4, 2025 - 05:33 GMT

24-Month Clinical results for Healionics’ STARgraft featured at CiDA conference

SEATTLE, WA, UNITED STATES, November 3, 2025 /⁨EINPresswire.com⁩/ -- Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced the presentation of 24-month clinical results for its STARgraft arteriovenous (AV) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2025 - 19:23 GMT

Healionics Granted US Patent for STARgraft Technology

SEATTLE, WA, UNITED STATES, April 2, 2025 /⁨EINPresswire.com⁩/ -- Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced that the U.S. Patent and Trademark Office has issued patent no. 12,263,077 titled “ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 14, 2024 - 14:29 GMT

Healionics’ STARgraft Receives FDA Breakthrough Device Designation

SEATTLE, WA, UNITED STATES, November 14, 2024 /⁨EINPresswire.com⁩/ -- Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced that its STARgraft arteriovenous graft – designed to provide a safer and more reliable …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 7, 2024 - 20:10 GMT

Healionics announces 12-month clinical results for STARgraft

SEATTLE, WA, USA, August 7, 2024 /⁨EINPresswire.com⁩/ -- Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced 12-month clinical results in the ongoing human trial of its STARgraft arteriovenous (AV) graft ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 23, 2024 - 15:50 GMT

Clinical results for Healionics’ STARgraft featured at VASA conference

SEATTLE, WA, USA, May 23, 2024 /⁨EINPresswire.com⁩/ -- Healionics Corporation, a developer of biomaterial-based medical devices, today announced positive clinical results in an ongoing human study of its STARgraft vascular graft. Results were presented at …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 10, 2024 - 06:02 GMT

Healionics Awarded $1.25M NIH Grant to Support Commercialization of STARgraft Vascular Graft

SEATTLE, WASHINGTON, USA, May 9, 2024 /⁨EINPresswire.com⁩/ -- Healionics Corporation, a developer of biomaterial-based medical devices, today announced it has been awarded a $1.25 million Small Business Innovation Research grant by the National Heart, Lung …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 22, 2024 - 22:43 GMT

Healionics Closes $5.5 Million Series A-3 Financing Round

SEATTLE, WA, USA, February 22, 2024 /⁨EINPresswire.com⁩/ -- Healionics Corporation, a developer of biomaterial-based medical devices, today announced the close of a $5.5 million equity financing round led by Keiretsu Capital with participation by several …

Distribution channels: Healthcare & Pharmaceuticals Industry ...